Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Anticipating PureCycle Technologies Quarterly Earnings A Look at Historical Performance and Investor Expectations

Elaine Mendonca by Elaine Mendonca
March 5, 2024
in Breaking News
0
Technology Blockchain Trading online
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

PureCycle Technologies (NASDAQ:PCT) is gearing up to unveil its quarterly earnings on March 6, 2024. Analysts are anticipating an EPS of $-0.23 for the company. Investors are eager to see PureCycle Technologies not only exceed this projection but also provide a promising outlook for future growth. It is important to remember that guidance often holds more sway over stock movement than simply meeting or missing earnings estimates.

In the previous quarter, PureCycle Technologies outperformed EPS expectations by $0.16, however, the share price plummeted by 16.94% the following day. Taking a look at past quarters, here is a recap of historical performance:
– Q3 2023: EPS Estimate -0.16, EPS Actual 0, Price Change % -17.0%
– Q2 2023: EPS Estimate -0.13, EPS Actual -0.35, Price Change % 3.0%
– Q1 2023: EPS Estimate -0.13, EPS Actual -0.16, Price Change % 5.0%
– Q4 2022: EPS Estimate -0.14, EPS Actual -0.05, Price Change % -6.0%

On March 4, PureCycle Technologies shares were trading at $6.04, reflecting a positive trend with a 7.66% increase over the past 52 weeks. This upward movement indicates optimism among long-term investors leading up to the upcoming earnings announcement.

For more comprehensive insights into PureCycle Technologies’ earnings releases and performance tracking, you can refer to their earnings calendar on various financial platforms such as Tipranks, MarketBeat, Nasdaq, and Yahoo Finance.

PCT Stock Price Drops by 4.39% on March 5, 2024

On March 5, 2024, PCT stock experienced a decline in its performance, with the price of shares dropping by $0.26 or 4.39% since the market last closed. The stock opened at $5.92, which was $0.12 lower than its previous close.

PCT Stock Analysis: Improving Net Income and EPS Trends in Q3 2024

On March 5, 2024, PCT stock showed some interesting performances based on the data provided by CNN Money. The total revenue for PCT was currently unavailable, which may have impacted the overall assessment of the company’s financial health. However, looking at the net income figures, it is clear that there have been some significant changes over the past year.

In the last year, PCT reported a net income of -$84.75 million, which is a substantial loss for the company. However, in the third quarter of the same year, the net income improved to $4.41 million, showing a significant increase of 107.79% since the previous quarter. Despite this improvement, the net income decreased by 9.35% compared to the previous year.

Similarly, the earnings per share (EPS) for PCT also showed some positive trends. The EPS for the last year was -$0.54, indicating a loss per share for investors. However, in the third quarter, the EPS improved to $0.00, showing a significant increase of 101.33% since the previous quarter. The EPS also increased by 27.84% compared to the previous year.

Overall, these figures suggest that PCT has been able to improve its financial performance in the most recent quarter compared to the previous year. Investors may see this as a positive sign for the company’s future prospects. However, the lack of total revenue data makes it difficult to assess the overall financial health of the company accurately. It is essential for investors to keep an eye on future financial reports to get a better understanding of PCT’s performance in the market.

Tags: PCT
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finances

Enhabit NYSE EHAB Earnings Report Preview and Analysis

Finance analyst

Guggenheim Analyst Reiterates Buy Rating on Prime Medicine with Revised Price Target

Investings on laptop and finances

LB Foster Company Reports Diverse Financial Performance in Q4 FY23 and Provides FY24 Outlook

Recommended

Transportation Stock Bull Market

JR Kyushu Implements AIPowered AMD Kria K26 SOM for Enhanced Track Inspection Efficiency and Safety

2 years ago
TMUS stock news

Wedbush Analyst Maintains Outperform Rating and Raises Price Target for Global Payments

2 years ago
JD.com Stock

JD.com Shares Surge on Robust Performance and Strategic Moves

3 months ago
Mobile-handsets

Palantir Technologies Reveals Revenue Projections for Q1 2024

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Procter & Gamble Shares Approach a Critical Juncture

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

Palantir Shares: A Wall Street Divide and a Bold New Price Target

Nvidia Accelerates AI Dominance with Early Chip Launch and Strategic Expansions

Netflix Shares Under Pressure Amid High-Stakes Acquisition Battle

Marvell Technology Shares Face Conflicting Market Cues

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

by Felix Baarz
January 11, 2026
0

The shares of Viking Therapeutics, a biotechnology firm, are presenting investors with a conflicting narrative this week....

Astera Labs Stock

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

January 11, 2026
Realty Income Stock

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

January 11, 2026
Procter & Gamble Stock

Procter & Gamble Shares Approach a Critical Juncture

January 11, 2026
Vital Farms Stock

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: A Tale of Clinical Progress and Insider Selling
  • Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals
  • Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com